The Super Jake Foundation applauds the FDA and United Therapeutics for the approval of Unituxin, a new treatment for high-risk neuroblastoma. As an orphan disease with no known cure, and very few treatment options, this new weapon is welcome and exciting news for patients and families waging this war.
Read the article here: FDA Approves New Neuroblastoma Drug
